Caris Life Sciences Director Danny Phillips Receives Award (13,192 RSUs)

What Happened
Danny Phillips, a director of Caris Life Sciences (CAI), was granted 13,192 restricted stock units (RSUs) on August 14, 2026. The grant is reported at $0.00 per share (standard for awards) and has a reported acquisition value of $0. This is an equity award, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-08-14 (reported on Form 4 filed 2026-08-14).
• Transaction type: Award/Grant (code A) — 13,192 RSUs granted at $0.00.
• Shares owned after transaction: Not specified in the information provided in this summary.
• Footnote: F1 — These RSUs vest in accordance with the applicable grant agreement (vesting schedule and conditions apply).
• Filing timeliness: Filed the same day as the transaction date in this filing (no late filing indicated).

Context

• RSU awards represent a promise of shares that typically vest over time or upon meeting conditions; they do not require an immediate cash outlay by the insider.
• Awards are common for compensating directors and do not by themselves signal a buy/sell decision. Any future sales or purchases after vesting would be reported separately.